Literature DB >> 23647546

Metallo-β-lactamases: structural features, antibiotic recognition, inhibition, and inhibitor design.

Jing-Fang Wang1, Kuo-Chen Chou.   

Abstract

Owing to their ability in destroying or slowing down the growth of bacteria, antibiotics have been widely used to treat the bacterial infections. However, because of the long-term and irresponsible use of antibiotics, resistance to antibiotics has become a serious problem directly threatening the public health worldwide. To fight against and resist β- lactam antibiotics, bacteria usually employed β-lactamases, especially the metallo-β-lactamases, to hydrolyze the C-N bond of the β-lactam ring so as to inactivate the antibiotics. In this minireview, we are to summarize the structural features of the metallo-β-lactamases, as well as their antibiotic binding modes and resistance mechanisms, in hopes that the discussion and analysis presented in this paper can stimulate new strategies to overcome the resistance problem and find novel inhibitors against the metallo-β-lactamases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647546     DOI: 10.2174/15680266113139990011

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

1.  Conformational dynamics of metallo-β-lactamase CcrA during catalysis investigated by using DEER spectroscopy.

Authors:  Mahesh Aitha; Lindsay Moritz; Indra D Sahu; Omar Sanyurah; Zahilyn Roche; Robert McCarrick; Gary A Lorigan; Brian Bennett; Michael W Crowder
Journal:  J Biol Inorg Chem       Date:  2015-02-10       Impact factor: 3.358

Review 2.  β-lactam/β-lactamase inhibitor combinations: an update.

Authors:  Kamaleddin H M E Tehrani; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

3.  Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition.

Authors:  Guo-Bo Li; Jürgen Brem; Robert Lesniak; Martine I Abboud; Christopher T Lohans; Ian J Clifton; Sheng-Yong Yang; Juan-Carlos Jiménez-Castellanos; Matthew B Avison; James Spencer; Michael A McDonough; Christopher J Schofield
Journal:  Chem Commun (Camb)       Date:  2017-05-30       Impact factor: 6.222

Review 4.  Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria.

Authors:  Laurent Dortet; Laurent Poirel; Patrice Nordmann
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

5.  Antibiotic Consumption Trends in China: Evidence From Six-Year Surveillance Sales Records in Shandong Province.

Authors:  Yan Song; Zhiyan Han; Kuimeng Song; Tianmin Zhen
Journal:  Front Pharmacol       Date:  2020-04-17       Impact factor: 5.810

6.  Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010-2014.

Authors:  Lidao Bao; Rui Peng; Yi Wang; Ruilian Ma; Xianhua Ren; Wenbin Meng; Fusheng Sun; Junxia Fang; Ping Chen; Yang Wang; Qiuhong Chen; Jian Cai; Jian Jin; Jinhui Guo; Shucheng Yang; Xiaomei Mo; Enjing Zhang; Yuerong Zhang; Zhaoxin Lu; Binbin Chen; Xiujuan Yue; Meijun Zhu; Yingying Wang; Xinchao Li; Yuan Bian; Shaoshan Kong; Wenfei Pan; Qian Ding; Jun Cao; Rupin Liu; Nan Chen; Xuelian Huang; Agula B; Haijun Lyu
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

7.  Trends in Antimicrobial Prescription for Inpatients in Changsha, China, 2003 to 2014.

Authors:  Yinhua Zhang; Qun Yuan; Xia Yi; Honghua Liu; Xiaoyan Pan; Jingwei Liu; Yi Xu; Yang Chen; Guoping He
Journal:  Iran J Public Health       Date:  2017-09       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.